There is much uncertainty around Brexit currently and we have received some enquiries in recent weeks from patients concerned about their supply of medicines. Whether it is a no-deal Brexit or the agreement brokered by the prime minister, leaving the European Union promises to have a profound impact on patients and the wider NHS. Click to read more.
Ensuring pituitary patients have security of supply for their essential medicines and therapies: Westminster’s Commons Select Committee on Health and Social Care is conducting an inquiry into Brexit preparations for a possible No-Deal outcome on 29 March 2019.
SMC has accepted hydrocortisone granules for restricted use for the replacement therapy of adrenal insufficiency.
Vaccination against pneumonia and influenza is commonly given to groups, such as the elderly or very young, or those who are most at risk. Read more here.
August 2018 - Concordia International have given their latest update on the supplies of Hydrocortisone Sodium Phosphate (ex Efcortesol).
Diabetes Insipidus – time to change the name?
Advice for how diabetes insipidus patients should manage their symptoms in the hot summer weather.
November 2017 - Concordia International have given their latest update on the supplies of Hydrocortisone Sodium Phosphate (ex Efcortesol).
There is a new generic hydrocortisone tablet which is both lactose-free and maize free. Read here the description that Resolution Chemicals have given about the new tablet.
There is now a pump version available to deliver Testogel.
